NECTAR LIFESCIENCES
|
NECTAR LIFESCIENCES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -15.08 | -5.07 | 0.22 | -1.08 | 1.12 |
| CEPS(Rs) | -2.93 | 0.06 | 2.93 | 1.56 | 3.66 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 29.98 | 42.63 | 47.68 | 47.47 | 48.51 |
| Tax Rate(%) | 34.74 | 34.98 | 72.66 | 42.99 | 26.51 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | - | - | 7.87 | 3.03 | 8.23 |
| EBIT Margin(%) | - | - | 5.60 | 2.69 | 5.86 |
| Pre Tax Margin(%) | - | - | 0.95 | -2.43 | 1.77 |
| PAT Margin (%) | - | - | 0.26 | -1.38 | 1.30 |
| Cash Profit Margin (%) | - | - | 3.41 | 2.00 | 4.26 |
| Performance Ratios | |||||
| ROA(%) | -4.80 | 0.03 | 0.23 | -1.06 | 1.05 |
| ROE(%) | -7.46 | 0.07 | 0.47 | -2.25 | 2.33 |
| ROCE(%) | -4.75 | 0.59 | 6.12 | 2.49 | 5.77 |
| Asset Turnover(x) | - | - | 0.88 | 0.77 | 0.81 |
| Sales/Fixed Asset(x) | - | - | 1.22 | 1.12 | 1.23 |
| Working Capital/Sales(x) | - | - | 6.19 | 5.13 | 5.49 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | - | - | 0.82 | 0.89 | 0.81 |
| Receivable days | - | - | 62.43 | 75.92 | 77.89 |
| Inventory Days | - | - | 130.94 | 139.23 | 118.26 |
| Payable days | - | - | 112.09 | 109.47 | 107.25 |
| Valuation Parameters | |||||
| PER(x) | - | - | 135.18 | - | 21.53 |
| PCE(x) | -3.17 | 391.90 | 10.28 | 10.18 | 6.58 |
| Price/Book(x) | 0.31 | 0.54 | 0.63 | 0.33 | 0.50 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | - | - | 0.77 | 0.72 | 0.83 |
| EV/Core EBITDA(x) | -1.37 | 105.53 | 7.66 | 10.29 | 8.13 |
| EV/EBIT(x) | -1.36 | 112.32 | 11.97 | 23.26 | 12.24 |
| EV/CE(x) | 0.12 | 0.70 | 0.76 | 0.60 | 0.71 |
| M Cap / Sales | - | - | 0.40 | 0.23 | 0.32 |
| Growth Ratio | |||||
| Net Sales Growth(%) | - | -100.00 | 10.53 | -8.70 | 8.13 |
| Core EBITDA Growth(%) | -589.97 | -93.94 | 58.97 | -37.56 | 50.54 |
| EBIT Growth(%) | -625.09 | -91.10 | 129.83 | -58.42 | 314.00 |
| PAT Growth(%) | -8,327.69 | -86.05 | 120.66 | -196.55 | 134.19 |
| EPS Growth(%) | -197.43 | -2,375.91 | 120.66 | -196.55 | 134.19 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | 0.61 | 0.59 | 0.71 | 0.79 |
| Current Ratio(x) | 9.71 | 1.21 | 1.32 | 1.38 | 1.35 |
| Quick Ratio(x) | 9.70 | 0.54 | 0.59 | 0.63 | 0.69 |
| Interest Cover(x) | -1.34 | 1.13 | 1.20 | 0.53 | 1.43 |
| Total Debt/Mcap(x) | - | 1.13 | 0.94 | 2.12 | 1.59 |
Compare Financial Ratios of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹254.7 Cr | 23.3% | 28.5% | -18% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,994.0 Cr | -0% | -4.5% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,249.0 Cr | 5.9% | 16.1% | 49.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,135.0 Cr | 3% | 3% | 34% | Stock Analytics | |
| CIPLA | ₹114,708.0 Cr | -0.4% | -3.6% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.9 Cr | NA | 2.8% | -7.1% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | 23.3% |
28.5% |
-18% |
| SENSEX | -0.8% |
0.2% |
-6% |
You may also like the below Video Courses
